Ribocure Pharmaceuticals

Mölndal, Sweden

Ribocure Pharmaceuticals is a biotech company specializing in the development of RNA-based and oligonucleotide therapeutics.

$33.0M raised

Jul 2025

Undisclosed

Biotechnology Pharmaceutical Therapeutics

Top Investors

Erik Selin Jacob Torell

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ribocure Pharmaceuticals

How much funding has Ribocure Pharmaceuticals raised?

Ribocure Pharmaceuticals has raised $33.0M in total funding. The most recent round was Undisclosed. The last funding was announced in July 2025.

Who are Ribocure Pharmaceuticals's investors?

Ribocure Pharmaceuticals's investors include Erik Selin, Jacob Torell.

Where is Ribocure Pharmaceuticals headquartered?

Ribocure Pharmaceuticals is headquartered in Mölndal, Sweden.

What does Ribocure Pharmaceuticals do?

Ribocure Pharmaceuticals is a biotech company specializing in the development of RNA-based and oligonucleotide therapeutics.

What stage is Ribocure Pharmaceuticals at?

Ribocure Pharmaceuticals is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 2, 2025.

MLA

"Ribocure Pharmaceuticals — Funding & Investors." VCBacked, July 2, 2025, https://www.vcbacked.co/company/ribocure-pharmaceuticals. Accessed July 3, 2026.

APA

VCBacked. (2025). Ribocure Pharmaceuticals — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/ribocure-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Ribocure Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/ribocure-pharmaceuticals |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 2, 2025.